IRIS
FRIERI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.604
EU - Europa 2.534
AS - Asia 2.459
SA - Sud America 268
Continente sconosciuto - Info sul continente non disponibili 109
AF - Africa 18
OC - Oceania 7
AN - Antartide 1
Totale 10.000
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.521
SG - Singapore 967
IE - Irlanda 581
CN - Cina 573
RU - Federazione Russa 482
SE - Svezia 310
TR - Turchia 281
HK - Hong Kong 251
DE - Germania 240
BR - Brasile 226
VN - Vietnam 226
IT - Italia 222
GB - Regno Unito 196
UA - Ucraina 163
FR - Francia 128
FI - Finlandia 97
CA - Canada 42
IN - India 33
JP - Giappone 28
BD - Bangladesh 24
BE - Belgio 21
CZ - Repubblica Ceca 21
MX - Messico 21
AR - Argentina 19
NL - Olanda 18
PL - Polonia 16
ES - Italia 14
ID - Indonesia 12
IQ - Iraq 12
CO - Colombia 7
AU - Australia 6
CR - Costa Rica 6
EC - Ecuador 6
EU - Europa 6
UZ - Uzbekistan 6
LT - Lituania 5
ZA - Sudafrica 5
KR - Corea 4
PH - Filippine 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
EE - Estonia 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KW - Kuwait 3
LU - Lussemburgo 3
MA - Marocco 3
NP - Nepal 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
CG - Congo 2
GE - Georgia 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
MY - Malesia 2
NI - Nicaragua 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
AQ - Antartide 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
SC - Seychelles 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 9.897
Salva come PNG Salva come JPEG
Città #
Jacksonville 647
Chandler 614
Dublin 581
Singapore 577
San Jose 445
Dallas 271
Hong Kong 249
Ashburn 240
Santa Clara 205
Boardman 191
Council Bluffs 176
Izmir 135
Nanjing 135
New York 122
Ann Arbor 110
San Mateo 108
The Dalles 86
Beijing 85
Lawrence 85
Princeton 84
Moscow 80
Ho Chi Minh City 78
Wilmington 73
Lauterbourg 54
Hanoi 52
Los Angeles 44
Milan 44
Woodbridge 39
L'aquila 33
Dearborn 31
Nanchang 31
São Paulo 29
Hefei 28
Munich 27
Des Moines 25
Verona 24
Shanghai 23
Shenyang 23
Tokyo 23
Seattle 22
Brussels 21
Kunming 21
Tianjin 21
Bremen 20
Orem 20
Brno 18
Hebei 18
London 18
Jiaxing 17
Montreal 17
Jinan 16
Rome 16
Warsaw 16
Frankfurt am Main 15
Norwalk 15
Turku 14
Mexico City 13
Mountain View 13
Stockholm 13
Columbus 12
Dong Ket 12
Helsinki 12
L’Aquila 12
Boston 11
Changsha 11
Ningbo 11
Amsterdam 10
Chennai 10
Poplar 10
Da Nang 9
Hangzhou 9
Brooklyn 8
Rio de Janeiro 8
Toronto 8
Auburn Hills 7
Brasília 7
Chicago 7
Manchester 7
Phoenix 7
Ankara 6
Atlanta 6
Buffalo 6
Falls Church 6
Florence 6
Houston 6
San Francisco 6
Tappahannock 6
Zhengzhou 6
Berlin 5
Dhaka 5
Falkenstein 5
Guangzhou 5
Haiphong 5
Hải Dương 5
Jakarta 5
Philadelphia 5
Quito 5
Sydney 5
Taizhou 5
Tashkent 5
Totale 6.553
Salva come PNG Salva come JPEG
Nome #
Association between vasomotor rhinitis and irritable bowel syndrome. 235
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 179
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 170
Histological healing in ulcerative colitis with mesalazine and its prognostic role 162
IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature 162
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 159
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 157
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 156
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 156
Association between colonic diverticula and colorectal polyps and cancer 151
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 149
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 149
Association between colorectal polyps and colonic diverticulosis 147
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 146
GI distension in severe ulcerative colitis 145
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 136
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 135
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 135
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 134
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 130
Il 5-ASA (Asacol) previene le recidive post-operatorie del morbo di Crohn. Risultati dello studio GISC a tre anni di follow-up. 128
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 127
Mucosal healing: Mayo 0 vs 1 after 3 years. 123
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 123
Is mesalazine treatment effective in the prevention of diverticulitis? A review 123
Ulcerative Colitis: rectal dilations in a patient with refractory diarrhoea. Report of a case 122
Celiac disease, gluten-free diet, and metabolic and liver disorders 122
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 121
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 121
Duodenal lymphocytosis in functional dyspepsia 121
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-β1 downregulation 120
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 119
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 119
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity 119
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 119
Early acid perception in NERD 117
Acute colitis following colonoscopy 115
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 115
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010 113
Colonic electromyography in chronic constipation. 112
Carbonic andhydrase I reduction in colonic mucosa of patients with active ulcerative colitis 112
Prognostic factors for post-operative recurrence of Crohn's disease 112
Colonoscopic control of uretero-enteric anastomoses in internal urinary diversion. 111
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 111
n-Butyrate Rectal Transport in Cirrhotic Patients 111
Short-chain fatty acids topical treatment in distal ulcerative colitis 110
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 110
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease 109
Incidence of inflammatory Bowel disease in Italy: A nationwide population-based study 108
Assesment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhancement MRI 108
The role on endoscopy in alcohol-related diseases 108
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled Pilot Study 107
Dextran sulfate sodium (DSS) colitis in rats. Clinical, structural, and ultrastructual aspects 107
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis 107
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 105
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. 104
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine 103
An unusual treatment for a colonic polyp. 101
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 101
Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. 100
Current opinions on treatment of inflammatory bowel disease 100
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 99
Abnormal Patterns of Colonic Mucin Secretion after Ureterosigmoidostomy 99
Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic biopsy samples in humans by high-performance liquid chromatography with electrochemical detection 99
Multiple organ dysfunction in ulcerative colitis 98
Abnormalities of colonic mucin secretion and metabolic changes after internal urinary diversion for bladder extrophy. A prospective study. 98
Management of colonic diverticular disease. 96
Abnormal Patterns of Colorectal Mucin Secretion after Urinary Diversion of Different Types: Histochemical and Lectin Binding Studies 96
Report of the 3rd National Congress of the Italian Federation of Coloproctology. 96
Historical evolution of the management of severe ulcerative colitis 94
Consequence of colonic involvement on electrolyte and acid-base homeostasis in crohn's disease 94
Mucosal 5-ASA concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis 94
Mesalazine vanishing time from rectal mucosa following its topical administration. 94
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 92
The long journey of salicylates in ulcerative colitis: The past and the future. 92
Italian consensus guidelines for chronic pancreatitis. 92
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's Patients 91
Gastrointestinal: Eosinophilic ascites. 90
Risk factors in toxic megacolon 89
Faecal excretion of bicarbonate in ulcerative colitis 89
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick? 87
Meccanismi e approccio alla fisiopatologia della diarrea. 84
Genetic analysis in italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study 81
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 79
The dyspeptic macrophage 30 years later. An update in the pathogenesis of Crohn's disease 74
Thecnical performance of colonoscopy: thekey role of sedation/analgesia and other quality indicators 66
Totale 10.000
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.481
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022529 0 49 129 44 23 4 10 31 25 28 37 149
2022/20231.714 116 97 30 197 152 186 0 116 740 7 47 26
2023/2024390 56 22 17 60 27 112 21 18 0 9 5 43
2024/20251.495 18 25 145 36 150 130 228 163 344 70 104 82
2025/20263.055 125 260 176 383 320 235 587 114 236 347 220 52
2026/2027181 77 104 0 0 0 0 0 0 0 0 0 0
Totale 10.000